Supraventricular tachycardia AHA recommendations for Management of SVT of Unknown Mechanism: Difference between revisions
Aysha Aslam (talk | contribs) No edit summary |
Aysha Aslam (talk | contribs) |
||
Line 18: | Line 18: | ||
|- | |- | ||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''2.'''Adenosine is recommended for acute treatment in patients with regular SVT ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B-R ]])'' <nowiki>"</nowiki> | | bgcolor="LightGreen"|<nowiki>"</nowiki>'''2.'''Adenosine is recommended for acute treatment in patients with regular SVT </nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B-R]])'' <nowiki>"</nowiki> | ||
|- | |- | ||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''3.'''Synchronized cardioversion is recommended for acute treatment in patients with hemodynamically unstable SVT when vagal maneuvers or adenosine are ineffective or not feasible ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B-NR]])'' <nowiki>"</nowiki> | | bgcolor="LightGreen"|<nowiki>"</nowiki>'''3.'''Synchronized cardioversion is recommended for acute treatment in patients with hemodynamically unstable SVT when vagal maneuvers or adenosine are ineffective or not feasible <nowiki>"</nowiki>'' ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B-NR]])'' <nowiki>"</nowiki> | ||
|- | |- | ||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''. | | bgcolor="LightGreen"|<nowiki>"</nowiki>'''4.'''Synchronized cardioversion is recommended for acute treatment in patients with hemodynamically stable SVT when pharmacological therapy is ineffective or contraindicated <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B-NR]])'' <nowiki>"</nowiki> | ||
Line 33: | Line 33: | ||
| colspan="1" style="text-align:center; background:LemonChiffon"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]] | | colspan="1" style="text-align:center; background:LemonChiffon"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]] | ||
|- | |- | ||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.''' Intravenous diltiazem or verapamil can be effective for acute treatment in patients with hemodynamically stable | |bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.''' Intravenous diltiazem or verapamil can be effective for acute treatment in patients with hemodynamically stable SVT <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence:B-R]])'' <nowiki>"</nowiki> | ||
SVT ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B-R]])'' <nowiki>"</nowiki> | |||
|- | |- | ||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''2.''' Intravenous beta blockers are reasonable for acute treatment in patients with hemodynamically stable SVT | |bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''2.''' Intravenous beta blockers are reasonable for acute treatment in patients with hemodynamically stable SVT <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C-LD]])'' <nowiki>"</nowiki> | ||
|- | |- | ||
|} | |} | ||
==References== | ==References== |
Revision as of 18:32, 25 October 2016
Resident Survival Guide |
Supraventricular tachycardia Microchapters |
Differentiating Among the Different Types of Supraventricular Tachycardia |
---|
Differentiating Supraventricular Tachycardia from Ventricular Tachycardia |
Diagnosis |
Treatment |
2015 ACC/AHA Guideline Recommendations |
Case Studies |
Supraventricular tachycardia AHA recommendations for Management of SVT of Unknown Mechanism On the Web |
American Roentgen Ray Society Images of Supraventricular tachycardia AHA recommendations for Management of SVT of Unknown Mechanism |
FDA on Supraventricular tachycardia AHA recommendations for Management of SVT of Unknown Mechanism |
CDC on Supraventricular tachycardia AHA recommendations for Management of SVT of Unknown Mechanism |
Blogs on Supraventricular tachycardia AHA recommendations for Management of SVT of Unknown Mechanism |
Directions to Hospitals Treating Supraventricular tachycardia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Aysha Anwar, M.B.B.S[2]
Overview
Management of SVT of Unknown Mechanism
Class I |
"1.Vagal maneuvers are recommended for acute treatment in patients with regular SVT "(Level of Evidence: B-R) " |
"2.Adenosine is recommended for acute treatment in patients with regular SVT </nowiki>"</nowiki>(Level of Evidence: B-R) " |
"3.Synchronized cardioversion is recommended for acute treatment in patients with hemodynamically unstable SVT when vagal maneuvers or adenosine are ineffective or not feasible " (Level of Evidence: B-NR) " |
"4.Synchronized cardioversion is recommended for acute treatment in patients with hemodynamically stable SVT when pharmacological therapy is ineffective or contraindicated "(Level of Evidence: B-NR) "
|
Class IIa |
"1. Intravenous diltiazem or verapamil can be effective for acute treatment in patients with hemodynamically stable SVT "(Level of Evidence:B-R) "
|
"2. Intravenous beta blockers are reasonable for acute treatment in patients with hemodynamically stable SVT "(Level of Evidence: C-LD) " |